Femasys Inc (FEMY)
Healthcare
Medical Instruments & Supplies
2.90 $
-1.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Femasys Inc (FEMY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 82.6% of the shares are freely tradable; institutional investors hold 10.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
10.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
9.3%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
82.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
6.9%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
3Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Dauntless Investment Group, LLC | 9.82 | 5,931,890 | +242.4 | 12/31/2025 |
| Vanguard Group Inc | 2.34 | 1,415,555 | +48.7 | 12/31/2025 |
| Vanguard Capital Management, LLC | 2.05 | 1,236,673 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 1.03 | 621,366 | +59.6 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.41 | 249,876 | +0.0 | 03/31/2026 |
| BlackRock Inc | 0.30 | 178,501 | +31.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.03 | 619,461 | +0.0 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.93 | 558,739 | +0.0 | 04/30/2026 |
| Fidelity Extended Market Index | 0.61 | 365,918 | -0.4 | 04/30/2026 |
| Abante Quant Value FI | 0.30 | 178,824 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.